← Insider buys

Krishna Kittu Kolluri has bought stock on 4 days since Jan 2016

10% owner at Interleukin Genetics Inc, and 2 other companies

SEC CIK 0001270521 · Filings on SEC.gov ↗

$47.0MBought
$0Sold
Aug 2Last buy

Krishna Kittu Kolluri's record

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Companies

Every filing

4 filings since Jan 2016, newest first

About Krishna Kittu Kolluri

Mr. Krishna “Kittu” Kolluri is a Silicon Valley venture capitalist and technology executive who has served as a 10% owner and corporate insider of Interleukin Genetics Inc. (ILIU) through his role with NEA-affiliated investment entities.( A veteran of more than three decades in the technology industry, he is the Founder and Managing Director of Neotribe Ventures, an early- and growth-stage venture capital firm investing in companies that tackle hard technical problems and disrupt non-traditional sectors.( He previously served as a General Partner at New Enterprise Associates (NEA), one of the world’s leading venture capital firms, focusing on information technology investments and serving on multiple portfolio company boards.(

Kolluri’s career includes senior leadership roles at several influential technology companies. He co‑founded Healtheon, which later merged with WebMD in a multibillion‑dollar transaction, where he became Senior Vice President and General Manager of Provider Services.( He went on to be President and CEO of Neoteris, a pioneer in Instant Virtual Extranet technology, which was acquired by NetScreen and subsequently by Juniper Networks, where he served as Executive Vice President and General Manager of the Security Products Group.( Earlier in his career he held engineering and management roles at Silicon Graphics, working on interactive TV projects.( Kolluri earned a B.Tech in Mechanical Engineering from the Indian Institute of Technology Madras (1986) and an M.S. in Operations Research from the State University of New York at Buffalo (1988).(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.